Deutsche Bank’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $172M | Buy |
|
|||||
|
2025
Q2 | $141M | Buy |
|
|||||
|
2025
Q1 | $129M | Sell |
|
|||||
|
2024
Q4 | $179M | Buy |
|
|||||
|
2024
Q3 | $138M | Buy |
|
|||||
|
2024
Q2 | $152M | Sell |
|
|||||
|
2024
Q1 | $228M | Sell |
|
|||||
|
2023
Q4 | $308M | Buy |
|
|||||
|
2023
Q3 | $241M | Sell |
|
|||||
|
2023
Q2 | $343M | Sell |
|
|||||
|
2023
Q1 | $456M | Sell |
|
|||||
|
2022
Q4 | $513M | Buy |
|
|||||
|
2022
Q3 | $428M | Sell |
|
|||||
|
2022
Q2 | $340M | Buy |
|
|||||
|
2022
Q1 | $303M | Sell |
|
|||||
|
2021
Q4 | $376M | Buy |
|
|||||
|
2021
Q3 | $391M | Sell |
|
|||||
|
2021
Q2 | $490M | Buy |
|
|||||
|
2021
Q1 | $360M | Buy |
|
|||||
|
2020
Q4 | $245M | Sell |
|
|||||
|
2020
Q3 | $335M | Buy |
|
|||||
|
2020
Q2 | $270M | Sell |
|
|||||
|
2020
Q1 | $338M | Sell |
|
|||||
|
2019
Q4 | $407M | Sell |
|
|||||
|
2019
Q3 | $418M | Buy |
|
|||||
|
2019
Q2 | $401M | Sell |
|
|||||
|
2019
Q1 | $500M | Buy |
|
|||||
|
2018
Q4 | $374M | Sell |
|
|||||
|
2018
Q3 | $589M | Buy |
|
|||||
|
2018
Q2 | $481M | Sell |
|
|||||
|
2018
Q1 | $963M | Buy |
|
|||||
|
2017
Q4 | $403M | Sell |
|
|||||
|
2017
Q3 | $494M | Sell |
|
|||||
|
2017
Q2 | $452M | Buy |
|
|||||
|
2017
Q1 | $436M | Buy |
|
|||||
|
2016
Q4 | $424M | Sell |
|
|||||
|
2016
Q3 | $545M | Sell |
|
|||||
|
2016
Q2 | $436M | Buy |
|
|||||
|
2016
Q1 | $323M | Sell |
|
|||||
|
2015
Q4 | $415M | Buy |
|
|||||
|
2015
Q3 | $330M | Buy |
|
|||||
|
2015
Q2 | $447M | Sell |
|
|||||
|
2015
Q1 | $467M | Buy |
|
|||||
|
2014
Q4 | $322M | Buy |
|
|||||
|
2014
Q3 | $295M | Sell |
|
|||||
|
2014
Q2 | $305M | Buy |
|
|||||
|
2014
Q1 | $274M | Sell |
|
|||||
|
2013
Q4 | $289M | Sell |
|
|||||
|
2013
Q3 | $364M | Buy |
|
|||||
|
2013
Q2 | $154M | Buy |
|